Structures by: Gzella A.


Structures by: Gzella A.

Results: 42


#NameUnit Cell
10000218,9-Dimethoxy-6,10b-dihydro-1-oxo-5H-thiazolo[2,3-a]isoquinolin-3-one
Acta Crystallographica, Section C (2001) 57, 12 1454-1456
a=19.967(2)
b=7.5484(9)
c=9.1666(13)
α= 90.00
β= 102.967(11)
γ= 90.00
V = 1346.3(3)
12000018,9-Dimethoxy-10b-methyl-1-oxo-6,10b-dihydro-5H- thiazolo[2,3-a]isoquinolin-3-one
Acta Crystallographica, Section C (2001) 57, 12 1454-1456
a=15.9407(15)
b=9.1737(10)
c=19.015(2)
α= 90.00
β= 90.00
γ= 90.00
V = 2780.7(5)
20032982C7H3N4O4,2C5H12N1
Acta Crystallographica Section C (1995) 51, 3 484-487
a=20.076(2)
b=6.831(2)
c=20.113(1)
α= 90
β= 90
γ= 90
V = 2758.3(9)
2003505C31H44O7
Acta Crystallographica Section C (1995) 51, 5 908-912
a=7.491(1)
b=12.188(2)
c=15.744(3)
α= 90.
β= 97.95(1)
γ= 90.
V = 1423.6(4)
2003506C32H46O7
Acta Crystallographica Section C (1995) 51, 5 908-912
a=7.709(1)
b=18.293(2)
c=21.082(3)
α= 90.
β= 90.
γ= 90.
V = 2973.0(7)
2003507C19H21N9O7
Acta Crystallographica Section C (1995) 51, 5 963-967
a=10.197(7)
b=10.623(1)
c=20.080(3)
α= 90
β= 101.53(2)
γ= 90
V = 2131.2(15)
20059259β-hydroxy-28-methoxy-11,28-dioxo-1,2-dinor-10α-18β-olean-12-en-3,10β-olide
Acta Crystallographica Section C (1997) 53, 2 261-264
a=6.776(1)
b=17.928(1)
c=21.642(1)
α= 90.00
β= 90.00
γ= 90.00
V = 2629.1(4)
20059269β-hydroxy-28-methoxy-11,28-dioxo-1,2-dinor-10α-18α-olean-12-en-3,10β-olide
Acta Crystallographica Section C (1997) 53, 2 261-264
a=10.303(1)
b=6.864(1)
c=18.844(1)
α= 90.00
β= 90.88(1)
γ= 90.00
V = 1332.5(2)
20059279α-hydroxy-28-methoxy-11,28-dioxo-1,2-dinor-10α-18α-olean-12-en-3,10β-olide
Acta Crystallographica Section C (1997) 53, 2 261-264
a=10.701(1)
b=12.771(2)
c=18.751(2)
α= 90.00
β= 90.00
γ= 90.00
V = 2562.6(5)
200763011α-hydroxy-28-methoxy-28-oxo-2,3-dinor-18β-olean-12-en-1,4-olide
Acta Crystallographica Section C (1998) 54, 9 1309-1312
a=9.8205(10)
b=10.9505(10)
c=25.645(2)
α= 90.00
β= 90.00
γ= 90.00
V = 2757.8(4)
200763128-methoxy-28-oxo-1,2-dinor-10α,18β-oleano-9,12-dien-3,10β-olide
Acta Crystallographica Section C (1998) 54, 9 1309-1312
a=6.5800(10)
b=12.1344(10)
c=32.338(2)
α= 90.00
β= 90.00
γ= 90.00
V = 2582.0(5)
2008577Olean-12-en[2,3-d]isoxazole-28-oic acid methyl ester
Acta Crystallographica Section C (1999) 55, 6 1031-1034
a=6.8800(8)
b=13.8033(9)
c=29.389(2)
α= 90.000(10)
β= 90.000(10)
γ= 90.000(10)
V = 2791.0(4)
200857819β,28-Epoxy-18Hα-oleanan[2,3-d]isoxazole
Acta Crystallographica Section C (1999) 55, 6 1031-1034
a=6.5284(10)
b=30.614(2)
c=13.5481(10)
α= 90.000(10)
β= 101.310(10)
γ= 90.000(10)
V = 2655.1(5)
20089233-chloro-1-(4,5-dinitroimidazolyl)propan-2-ol
Acta Crystallographica Section C (1999) 55, 9 1562-1565
a=10.3098(13)
b=8.4972(8)
c=11.4264(13)
α= 90.000
β= 90.000
γ= 90.000
V = 1001.00(19)
20089243-Chloro-1-(4-nitro-5-piperidinylimidazolyl)propan-2-ol
Acta Crystallographica Section C (1999) 55, 9 1562-1565
a=10.7630(10)
b=16.052(2)
c=16.634(2)
α= 75.870(10)
β= 82.880(10)
γ= 89.910(10)
V = 2764.1(6)
20090272-Formyl-3-hydroxy-18Hβ-olean-2,12-dien-28-oic acid methyl ester
Acta Crystallographica Section C (1999) 55, 10 1730-1733
a=6.8848(8)
b=13.7645(10)
c=29.628(2)
α= 90.000(6)
β= 90.000(8)
γ= 90.000(8)
V = 2807.7(4)
20090282-Formyl-19β,28-epoxy-3-hydroxy-18Hα-olean-2-ene
Acta Crystallographica Section C (1999) 55, 10 1730-1733
a=6.6351(8)
b=12.7178(10)
c=15.6807(14)
α= 90.000(7)
β= 95.000(9)
γ= 90.000(9)
V = 1318.2(2)
20092883,28-Dimethoxy-3,11,28-trioxo-2,3-seco-18β-olean-12-en-2,9α-olide
Acta Crystallographica Section C (1999) 55, 12 2151-2153
a=29.143(4)
b=7.456(2)
c=14.855(2)
α= 90.00
β= 116.33(2)
γ= 90.00
V = 2893.0(11)
20092902-Oxo-18β-olean-12-en-28-oic acid methyl ester
Acta Crystallographica Section C (1999) 55, 12 2153-2156
a=11.3083(12)
b=13.5950(12)
c=17.9710(14)
α= 90.00
β= 90.00
γ= 90.00
V = 2762.8(4)
20092913-Oxo-18β-olean-12-en-28-oic acid methyl ester
Acta Crystallographica Section C (1999) 55, 12 2153-2156
a=6.8765(12)
b=13.6070(14)
c=29.118(3)
α= 90.00
β= 90.00
γ= 90.00
V = 2724.5(6)
20108183β-Hydroxy-11-oxo-18α-olean-12-en-28-oic acid methyl ester
Acta Crystallographica Section C (2000) 56, 4 505-507
a=13.425(3)
b=7.4226(12)
c=15.0382(17)
α= 90.00
β= 91.881(13)
γ= 90.00
V = 1497.7(4)
20108193,11-Dioxo-18α-olean-12-en-28-oic acid methyl ester
Acta Crystallographica Section C (2000) 56, 4 505-507
a=6.6304(12)
b=12.886(2)
c=31.442(5)
α= 90.00
β= 90.00
γ= 90.00
V = 2686.4(8)
2011224Methyl 3β-acetoxy-12-oxo-18β-olean-28-oate
Acta Crystallographica Section C (2000) 56, 8 983-985
a=7.0662(16)
b=22.083(3)
c=40.141(5)
α= 90.00
β= 90.00
γ= 90.00
V = 6263.7(18)
2011225Methyl 3β-acetoxy-12,19-dioxoolean-9(11),13(18)-dien-28-oate
Acta Crystallographica Section C (2000) 56, 8 983-985
a=7.9348(8)
b=15.8841(10)
c=12.1480(8)
α= 90.00
β= 99.041(7)
γ= 90.00
V = 1512.1(2)
2011226(4S,5S)-(+)-4-Hydroxymethyl-2,5-diphenyloxazoline
Acta Crystallographica Section C (2000) 56, 8 981-982
a=4.8995(10)
b=11.3300(13)
c=23.820(3)
α= 90.000
β= 90.000
γ= 90.000
V = 1322.3(4)
20113373-Chloro-1-(4-morpholinyl-5-nitroimidazol-1-yl)propan-2-ol
Acta Crystallographica Section C (2000) 56, 9 1161-1163
a=9.6840(8)
b=5.2868(8)
c=12.8212(7)
α= 90.00
β= 106.470(6)
γ= 90.00
V = 629.48(12)
20113383-Chloro-1-(5-morpholinyl-4-nitroimidazol-1-yl)propan-2-ol
Acta Crystallographica Section C (2000) 56, 9 1161-1163
a=6.5036(8)
b=7.8493(9)
c=12.9757(14)
α= 91.101(9)
β= 101.026(10)
γ= 101.940(10)
V = 634.91(13)
2011887(Z)-1-(4,5-dinitroimidazol-1-yl)-3-morpholinopropan-2-one 2,4-dinitrophenylhydrazone
Acta Crystallographica Section C (2001) 57, 4 462-466
a=9.0382(7)
b=19.2008(13)
c=11.9087(8)
α= 90
β= 96.579(6)
γ= 90
V = 2053.0(3)
2011888(Z)-1-(4-morpholino-5-nitroimidazol-1-yl)-3-morpholinopropan-2-one 2,4-dinitrophenylhydrazone
Acta Crystallographica Section C (2001) 57, 4 462-466
a=8.0664(6)
b=12.3698(10)
c=13.2280(13)
α= 111.282(8)
β= 106.037(7)
γ= 90.735(6)
V = 1172.55(19)
2011889(E)-1-(4-morpholino-5-nitroimidazol-1-yl)-3-morpholinopropan-2-one 2,4-dinitrophenylhydrazone tetrahydrofuran solvate
Acta Crystallographica Section C (2001) 57, 4 462-466
a=7.2885(6)
b=27.686(2)
c=14.3642(11)
α= 90
β= 101.707(8)
γ= 90
V = 2838.2(4)
20122735-Nitro-3-thiomorpholino-1H-indazole
Acta Crystallographica Section C (2001) 57, 10 1189-1191
a=4.3897(8)
b=10.4102(10)
c=25.829(3)
α= 90
β= 91.166(12)
γ= 90
V = 1180.1(3)
20122743-(4-methylpiperazino)-5-nitro-1H-indazole methanol hemisolvate water hemisolvate
Acta Crystallographica Section C (2001) 57, 10 1189-1191
a=7.3742(11)
b=12.1765(13)
c=16.6356(16)
α= 78.650(9)
β= 84.958(10)
γ= 74.596(11)
V = 1410.9(3)
2012369C14H17NO4S
Acta Crystallographica, Section C (2001) 57, 1454-1456
a=15.9407(15)
b=9.1737(10)
c=19.015(2)
α= 90.00
β= 90.00
γ= 90.00
V = 2780.7(5)
20128843-Hydroxymethyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline hydrobromide methanol hemisolvate
Acta Crystallographica Section C (2002) 58, 8 o503-o506
a=20.5882(14)
b=6.4413(6)
c=11.7354(6)
α= 90.00
β= 91.004(5)
γ= 90.00
V = 1556.0(2)
20128852-Formyl-3-hydroxymethyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline
Acta Crystallographica Section C (2002) 58, 8 o503-o506
a=11.097(2)
b=11.742(2)
c=21.829(4)
α= 90.00
β= 90.00
γ= 90.00
V = 2844.3(9)
2207458S-(-)-3-Chloro-1-(4-morpholino-5-nitro-1H-imidazol-1-yl)propan-2-ol
Acta Crystallographica, Section E (2005) 61, 12 o4232-o4231
a=9.677(2)
b=5.2910(10)
c=12.818(3)
α= 90.00
β= 106.45(3)
γ= 90.00
V = 629.4(2)
2207523(R)-(+)-2,3-Methylenedioxy-8-oxoberbine
Acta Crystallographica Section E (2005) 61, 12 o4165-o4166
a=7.3595(8)
b=9.2465(14)
c=20.323(3)
α= 90.00
β= 90.00
γ= 90.00
V = 1383.0(3)
2207611(R)-(+)-3-Chloro-1-(4-morpholino-5-nitro-1H-imidazol-1-yl)propan-2-ol
Acta Crystallographica Section E (2005) 61, 12 o4071-o4072
a=9.6835(16)
b=5.2925(13)
c=12.823(2)
α= 90.00
β= 106.470(15)
γ= 90.00
V = 630.2(2)
2207671(S)-(-)-2,3-methylenedioxy-8-oxoberbine
Acta Crystallographica Section E (2005) 61, 12 o4001-o4003
a=7.3551(19)
b=9.2458(12)
c=20.332(3)
α= 90
β= 90
γ= 90
V = 1382.7(4)
2208224(S)-(-)-2,3-Dimethoxy-8-oxoberbine
Acta Crystallographica Section E (2006) 62, 2 o598-o600
a=7.9530(12)
b=7.7145(12)
c=12.7627(12)
α= 90.00
β= 95.760(10)
γ= 90.00
V = 779.08(18)
22090961-(4-chlorophenacyl)-2-methyl-4,5-dinitroimidazole
Acta Crystallographica Section E (2006) 62, 6 o2168-o2170
a=20.094(3)
b=9.4907(14)
c=15.0418(17)
α= 90.00
β= 106.953(12)
γ= 90.00
V = 2743.9(7)
22174411-Methyl-2-(4-methylphenyl)-4-morpholinopyridazine-3,6(1H,2H)-dione
Acta Crystallographica Section E (2008) 64, 2 o435-o435
a=5.6246(6)
b=8.8923(6)
c=15.0842(10)
α= 90.00
β= 99.530(7)
γ= 90.00
V = 744.03(11)